InvestorsHub Logo
icon url

Smallville

07/13/17 4:36 PM

#103394 RE: zioni007 #103388

From your link....


'Of course, the question of how long this data will take to hit press is pertinent primarily because the longer it takes, the more cash this company has to spend to meet operational expenses. At the end of March, cash on hand came in at a little over $2 million. Chances are, then, that we are going to see a near-term raise to fund the ongoing investigations and – as a result – some degree of dilution on any early-stage positions'.

There's the answer as they started a paid promotion.
icon url

moxa1

07/13/17 6:08 PM

#103406 RE: zioni007 #103388

I think Insider Financial got this part wrong. They were looking for results of our safety study at clinicaltrials.org thinking they're being conducted in the US. They're not, they're being conducted in Israel.

This study was initially slated for completion during July, but a look at the protocol at clinicaltrials.org suggests there has been relatively little in terms of advance on the enrollment front, meaning it looks like there is some form of delay in getting the trial completed.